Skip to main navigation Skip to search Skip to main content

CD44 in Bladder Cancer

Research output: Contribution to journalReview articlepeer-review

Abstract

The glycoprotein CD44, with its many isoforms and variations in carbohydrate patterning, participates in a diverse set of cellular functions. This fact leads to the protein playing a role in many normal and pathologic cellular processes including a role in cancer progression and metastasis. These same facts make CD44 a strong therapeutic target in many cancer types, including bladder cancer.

Original languageEnglish (US)
Article number1195
JournalCancers
Volume16
Issue number6
DOIs
StatePublished - Mar 2024
Externally publishedYes

Keywords

  • androgen receptor
  • bladder cancer
  • CD44
  • glycosylation
  • hyaluronic acid

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'CD44 in Bladder Cancer'. Together they form a unique fingerprint.

Cite this